July 14, 2025

Predicting Naming Loss After Epilepsy Surgery

A study of patients who underwent epilepsy surgery in the language-dominant temporal lobe identified key risk factors for early naming decline and found that the degree of early decline predicts long-term recovery.

Conexiant

July 14, 2025

Laser Therapy Linked to Seizure Control in Drug-Resistant Epilepsy

In a multicenter study of patients with drug-resistant mesial temporal lobe epilepsy, laser thermal therapy led to seizure freedom in over half of participants after two years, with low complication rates and improved quality of life.

Conexiant

June 30, 2025

Breakthrough Device Approvals Outpacing Data

Many FDA-authorized breakthrough therapeutic devices may lack robust clinical testing.

Conexiant

June 30, 2025

Can Typos Change a Diagnosis?

Large language models used in clinical decision-making may offer different treatment recommendations depending on how a patient writes their message—even when the medical facts remain unchanged.

Conexiant

June 23, 2025

Is OLIF the Better Back Bet?

A study comparing two spine surgeries in older adults found that OLIF significantly reduced hospital stays, complications, and improved back structure compared with TLIF.

Conexiant

April 23, 2025

Sense of Belonging 'Critical' for Workplace Retention

Individuals who reported a neutral level of satisfaction with their sense of belonging were approximately 3 times more likely to express an intent to leave, while those who were dissatisfied were 7 times more likely to do so, compared to individuals who were satisfied with their sense of belonging.

Conexiant

May 14, 2025

Sevoflurane Sedation Linked to Lower ARDS Survival

A large French clinical trial found that patients with moderate to severe ARDS who received sevoflurane had fewer ventilator-free days and lower 90-day survival than those sedated with propofol.

Conexiant

May 22, 2025

Cardiogenic Shock in Women: Treatment Disparities Persist

New expert consensus statement reveals that women with cardiogenic shock face significant treatment disparities and outlines evidence-based recommendations for improving outcomes.

Conexiant

May 16, 2025

Removing NET on MRI Extends Glioblastoma Survival

A new multinational study found that removing the full extent of noncontrast-enhanced tumor seen on MRI scans led to significantly longer survival in patients with IDH wild-type glioblastoma.

Conexiant